Viewing Study NCT00802594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-05-23 @ 11:36 AM
Study NCT ID: NCT00802594
Status: COMPLETED
Last Update Posted: 2008-12-05
First Post: 2008-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis
Sponsor: Immtech Pharmaceuticals, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Trypanosomiasis, African View
Keywords:

Keywords

Keyword Brief Keyword Text View
None first stage View
None T.b. gambiense View
None sleeping sickness View
None Patients with first stage T.b. gambiense sleeping sickness View